tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

IDYA Stock Latest News

Ideaya Biosciences price target raised to $65 from $64 at Citi
The FlyIdeaya Biosciences price target raised to $65 from $64 at Citi
23h ago
IDYA
Ideaya Biosciences price target raised to $52 from $49 at Wedbush
PremiumThe Fly
Ideaya Biosciences price target raised to $52 from $49 at Wedbush
2d ago
IDYA
IDEAYA Biosciences: Buy Rating on Darovasertib/Crizotinib Ahead of Pivotal OpतimUM-02 Readout and Supported by Strong Cash Runway
PremiumRatings
IDEAYA Biosciences: Buy Rating on Darovasertib/Crizotinib Ahead of Pivotal OpतimUM-02 Readout and Supported by Strong Cash Runway
3d ago
IDYA
Ideaya Biosciences reports Q4 EPS (94c), consensus (95c)
PremiumThe Fly
Ideaya Biosciences reports Q4 EPS (94c), consensus (95c)
3d ago
IDYA
Ideaya Biosciences price target raised to $45 from $41 at RBC Capital
PremiumThe Fly
Ideaya Biosciences price target raised to $45 from $41 at RBC Capital
30d ago
IDYA
Multiple Shots on Goal in High-Unmet-Need Oncology: IDEAYA’s Diversified Pipeline and Strong Funding Underpin Buy Rating
PremiumRatingsMultiple Shots on Goal in High-Unmet-Need Oncology: IDEAYA’s Diversified Pipeline and Strong Funding Underpin Buy Rating
1M ago
IDYA
IDEAYA updates precision oncology strategy at JPM 2026
Premium
Company Announcements
IDEAYA updates precision oncology strategy at JPM 2026
1M ago
8K
IDYA
IDEAYA sets 2026 objectives to advance registrational trials
Premium
Company Announcements
IDEAYA sets 2026 objectives to advance registrational trials
1M ago
8K
IDYA
Ideaya Biosciences provides business update for 2026
PremiumThe Fly
Ideaya Biosciences provides business update for 2026
1M ago
IDYA
Ideaya Biosciences assumed with a Buy at UBS
PremiumThe Fly
Ideaya Biosciences assumed with a Buy at UBS
1M ago
IDYA
Aligos Therapeutics initiated with a Buy at UBS
PremiumThe Fly
Aligos Therapeutics initiated with a Buy at UBS
1M ago
IVA
KOD
Ideaya Biosciences price target raised to $60 from $59 at Truist
PremiumThe Fly
Ideaya Biosciences price target raised to $60 from $59 at Truist
1M ago
IDYA
Ideaya Biosciences Advances with IDE892 Study Targeting MTAP-Deleted Tumors
PremiumCompany AnnouncementsIdeaya Biosciences Advances with IDE892 Study Targeting MTAP-Deleted Tumors
2M ago
IDYA
IDEAYA Biosciences Faces Collaboration Termination by GSK
Premium
Company Announcements
IDEAYA Biosciences Faces Collaboration Termination by GSK
2M ago
8K
IDYA
Citi places Ideaya on ‘upside 90-day catalyst watch’ into data
Premium
The Fly
Citi places Ideaya on ‘upside 90-day catalyst watch’ into data
2M ago
IDYA
Promising Outlook for IDEAYA Biosciences: Buy Rating Backed by Positive Trial Expectations
PremiumRatings
Promising Outlook for IDEAYA Biosciences: Buy Rating Backed by Positive Trial Expectations
2M ago
IDYA
Ideaya Biosciences completes enrollment in OptimUM-02 trial
PremiumThe Fly
Ideaya Biosciences completes enrollment in OptimUM-02 trial
2M ago
PFE
IDYA
IDEAYA Biosciences: Promising Future with Innovative Dual KAT6/7 Inhibitor and Strong Financial Position
PremiumRatings
IDEAYA Biosciences: Promising Future with Innovative Dual KAT6/7 Inhibitor and Strong Financial Position
2M ago
IDYA
Ideaya Biosciences submits IDE574 IND application to FDA
PremiumThe Fly
Ideaya Biosciences submits IDE574 IND application to FDA
2M ago
IDYA
Ideaya financials not impacted by GSK termination, says Mizuho
PremiumThe FlyIdeaya financials not impacted by GSK termination, says Mizuho
2M ago
IDYA
Ideaya disclosed termination of GSK license agreement
Premium
The Fly
Ideaya disclosed termination of GSK license agreement
2M ago
GSK
IDYA
IDEAYA Biosciences: Strategic Positioning and Promising Oncology Assets Drive Buy Rating
Premium
Ratings
IDEAYA Biosciences: Strategic Positioning and Promising Oncology Assets Drive Buy Rating
3M ago
IDYA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >